Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences Raises $20M in New Funding

NEW YORK (GenomeWeb News) – Menlo Park, Calif.-based Pacific Biosciences today said that it recently received $20 million in funding from new investor Blackstone Cleantech Venture Partners.
 
With the new funds, Pac Bio has raised $120 million in its latest financing round. It plans to use the resources to support its efforts to bring its Single-Molecule, Real-Time DNA sequencing platform to the market by the second half of 2010. The company said it has raised $193 million since it was founded in 2004.
 
Pac Bio also announced today that Elaine Mardis, co-director of the Washington University School of Medicine Genome Sequencing Center, has joined its scientific advisory board. Mardis, who has been at the Genome Sequencing Center since 1993, said in a statement that she is “convinced that Pacific Biosciences has the technology that will allow for dramatic advances in sequencing and truly enable ultra fast, accurate, and inexpensive DNA sequencing.”

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.